Sino Biopharmaceutical to divest 67% stake in unit CP Qingdao for $253 mln
06 Feb 2024 //
REUTERS
Sino received IND approval from the NMPA to initiate trial with lanifibranor
25 May 2023 //
GLOBENEWSWIRE
06 Feb 2024 //
REUTERS
25 May 2023 //
GLOBENEWSWIRE